Latest Commercialization News

Black Canyon Limited reports breakthrough metallurgical test results from its Wandanya Project, producing manganese concentrates between 48% and 50% Mn, surpassing premium industry benchmarks. The findings pave the way for further exploration and potential commercial development.

Gyder Surgical, backed by Hydrix Ventures, has secured FDA 510(k) clearance for its innovative GYDER Hip System, opening the door to the lucrative U.S. market and increasing Hydrix’s investment value.

Alpha HPA has responded to ASX inquiries confirming the material market sensitivity of its signed Letter of Intent (LOI) and related surge in semiconductor sector sales, underscoring the strategic importance of its high purity materials.

Bass Oil Limited is set to deepen its exploration of the Triassic gas play in the northern Cooper Basin following a successful flow test at the Kiwi gas field, signaling significant potential for future discoveries and development.

Lithium Universe Limited has signed a non-binding MOU with Lafarge Canada for exclusive supply of aluminosilicate from its Bécancour refinery, aiming to boost cement durability and sustainability in Canada’s growing market.

Mt Malcolm Mines NL has completed bulk sampling at its Golden Crown Prospect, recovering 218 ounces of gold doré from high-grade material and generating over AUD$835,000 in revenue. The company is now advancing resource estimations and planning future mining strategies.

Mayur Resources has locked in $11.2 million in funding from Pacific Unison to kickstart production at its Orokolo Bay Industrial Sands Project in Papua New Guinea, targeting 500,000 tonnes of magnetite annually by late 2025.

BTC Health has transformed its decade-long license agreement with Arna Pharma into an indefinite partnership, gaining royalties from Singapore and Malaysia sales and first rights to new pharmaceutical products in Australia and New Zealand.

Micro-X has raised $3.3 million through a placement and institutional entitlement offer, reinforcing its strategic shift towards medical imaging technologies. A retail entitlement offer aiming to raise an additional $2.7 million will open shortly, supporting the company’s development of mobile X-ray and CT products.

Nanoveu Limited has completed the strategic acquisition of Embedded A.I. Systems Pte. Ltd. (EMASS), positioning itself at the forefront of ultra-low-power AI-driven edge semiconductor solutions. This move aims to enhance its EyeFly3D™ platform and expand into rapidly growing markets such as wearables, IoT, and autonomous devices.

BlinkLab has secured North Shore Pediatric Therapy as the second US clinical site in its autism diagnostic study, enhancing recruitment and data quality with a leading Chicago-based specialist.

CLINUVEL has released preliminary data from its CUV052 study showing SCENESSE® is well tolerated in adolescent erythropoietic protoporphyria (EPP) patients, supporting a planned label extension in 2025.